Oral administration of 1,000 mg/kg body weight per day of S. crispa for 4 weeks was shown to significantly accelerate wound healing in rats with streptozotocin- (STZ-) induced diabetes, which is an insulin-dependent model of diabetes mellitus (type 1) [42]. Here, INS is linked to diabetes mellitus.